Industry News
Pharmaceutical Industry News
Sales of Biogen’s Alzheimer’s Drug Fall Short of Expectations
The drug, Aduhelm, brought in $300,000 in revenue in its first full three months of availability. The company expects the drug to generate minimal revenue for the rest of the year.
Gates Foundation Pledges $120 Million to Help Get Merck Covid Pills to Poor Countries
Regulatory hurdles and supply chain issues could slow efforts to produce generic versions of Merck’s antiviral molnupiravir for developing nations, despite licensing agreements.
Iran Plans to Abandon One of Its Homegrown Covid Shots
The defense ministry said there was too little demand for its Fakhravac vaccine to justify producing it, and blamed the health ministry for reneging on promised orders.
Novavax struggling to meet quality standards in COVID-19 vaccine production push: report
Novavax struggling to meet quality standards in COVID-19 vaccine production push: report jkeenan Wed, 10/20/2021 - 14:19
Biogen, with sales falling sharply, posts ‘obviously disappointing’ Aduhelm sales of $300K, CEO Vounatsos says
Biogen, with sales falling sharply, posts 'obviously disappointing' Aduhelm sales of $300K, CEO Vounatsos says kdunleavy Wed, 10/20/2021 - 10:47
Roche gets a boost from COVID-19 drug Actemra, but Ocrevus lags as patients prep for boosters
Roche gets a boost from COVID-19 drug Actemra, but Ocrevus lags as patients prep for boosters aliu Wed, 10/20/2021 - 10:39
Pfizer strong-armed governments in COVID-19 vaccine supply talks, report says
Pfizer strong-armed governments in COVID-19 vaccine supply talks, report says esagonowsky Wed, 10/20/2021 - 10:34
Merck recalls 22K vials of Cubicin after customer finds glass shard
Merck recalls 22K vials of Cubicin after customer finds glass shard jkeenan Wed, 10/20/2021 - 09:21
AstraZeneca’s Soliris needs a 97% to 98% discount in myasthenia gravis, ICER says
AstraZeneca's Soliris needs a 97% to 98% discount in myasthenia gravis, ICER says esagonowsky Wed, 10/20/2021 - 09:18
The World’s View on Drugs Is Changing. Which Side Are You On?
Should we decriminalize drugs, or legalize?
Should Pregnant Women Get a Covid-19 Booster Shot?
Experts strongly agree that the shots benefit the mother as well as the fetus.
On heels of GBT Oxbryta campaign, ad agency launches pharma comms division, Riester RX
On heels of GBT Oxbryta campaign, ad agency launches pharma comms division, Riester RX nmissakian Tue, 10/19/2021 - 16:41
Mix-and-Match Covid Boosters: Why They Just Might Work
The F.D.A. may authorize booster shots of vaccines different from the ones that Americans originally received. The science behind the move is promising.
Lupin recalls blood pressure tablets on cancer-causing contamination concerns
Lupin recalls blood pressure tablets on cancer-causing contamination concerns jkeenan Tue, 10/19/2021 - 12:06
Despite legal troubles, Johnson & Johnson is in the financial driver’s seat for 2022 and beyond, CFO says
Despite legal troubles, Johnson & Johnson is in the financial driver's seat for 2022 and beyond, CFO says kdunleavy Tue, 10/19/2021 - 11:38
Failed cancer immunotherapies cost Medicare hundreds of millions. How should FDA revamp accelerated approvals?
Failed cancer immunotherapies cost Medicare hundreds of millions. How should FDA revamp accelerated approvals? aliu Tue, 10/19/2021 - 11:04
WHO plots multibillion-dollar campaign to buy COVID-19 antivirals for $10 per course: Reuters
WHO plots multibillion-dollar campaign to buy COVID-19 antivirals for $10 per course: Reuters esagonowsky Tue, 10/19/2021 - 10:32
FDA ready to bless mixing and matching of COVID-19 vaccines as boosters: report
FDA ready to bless mixing and matching of COVID-19 vaccines as boosters: report kdunleavy Tue, 10/19/2021 - 09:49
FDA missing more approval target dates as COVID slows inspections
FDA missing more approval target dates as COVID slows inspections jkeenan Tue, 10/19/2021 - 08:47
Oyster Point, with AbbVie and Novartis in its sights, wins first FDA approval for nasal spray to treat dry eye disease
Oyster Point, with AbbVie and Novartis in its sights, wins first FDA approval for nasal spray to treat dry eye disease ntaylor Tue, 10/19/2021 - 05:54